The FDA has granted a priority review to the supplemental Biologics License Application for enfortumab/pembrolizumab to all ...
First patient dosing occurred for JANX011 (NCT07291323), a CD19-targeted bispecific inaugurating the ARM platform to enable ...
Dr. Premal Thaker reports IMNN-001 shows early survival benefit in ovarian cancer by activating immune response directly in ...
Liquid biopsy ctDNA reveals targets and flags residual disease in esophageal and gastric cancers, hinting at earlier relapse ...
In this episode of The OncoloGIST, Dr Christine Bestvina of UChicago Medicine provides a comprehensive look at the rapidly ...
On-body injector isatuximab enables at-home myeloma treatment, cutting infusion visits, easing time and financial strain, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results